Cargando…
(188) Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)—A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy
Objective The incidence of inoperable hepatocellular carcinoma (HCC) with/without malignant portal vein thrombosis (PVT) is increasing in India for the last decade; thus, Bhabha Atomic Research Centre (BARC), Mumbai, India, developed diethydithiocarbamate (DEDC), a new transarterial radionuclide th...
Autores principales: | Kumar, Naresh, Gupta, Priyanka, Shamim, Shamim Ahmed, Chirayil, Viju, Subramanian, Suresh, Mallia, Madhava B., Bal, Chandrasekhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202571/ https://www.ncbi.nlm.nih.gov/pubmed/37223628 http://dx.doi.org/10.1055/s-0043-1764306 |
Ejemplares similares
-
(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside
por: Lepareur, Nicolas, et al.
Publicado: (2012) -
(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023) -
Rhenium-188 Hydroxyethane 1,1-Diphosphonic Acid (HEDP) for Bone Pain Palliation Using BARC-HEDP Kits versus Pars-HEDP Kits: A Comparison on Preparation and Performance Aspects at Hospital Radiopharmacy
por: Ramakurup, Radhakrishnan Edathuruthy Kalarickal, et al.
Publicado: (2018) -
Biodistribution, pharmacokinetics, and organ-level dosimetry for (188)Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans
por: Esquinas, Pedro L., et al.
Publicado: (2018) -
The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
por: Sun, HongLiang, et al.
Publicado: (2017)